Notify me when Martin Babler files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ALMS | ALUMIS INC. | President, CEO and Chairman, Director | $488,164 | +$100,733 | +26% | 29 Jul 2025 |
| ETNB | 89bio, Inc. | Director | 30 Oct 2025 | |||
| NGNE | Neurogene Inc. | Director | 08 Jun 2023 | |||
| PRLD | Prelude Therapeutics Inc | Director | 12 Jun 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|